Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · Real-Time Price · USD
6.14
+0.07 (1.15%)
Mar 17, 2026, 4:00 PM EDT - Market closed
Puma Biotechnology Employees
Puma Biotechnology had 179 employees as of December 31, 2025. The number of employees increased by 7 or 4.07% compared to the previous year.
Employees
179
Change (1Y)
7
Growth (1Y)
4.07%
Revenue / Employee
$1,275,816
Profits / Employee
$173,804
Market Cap
312.38M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 179 | 7 | 4.07% |
| Dec 31, 2024 | 172 | -13 | -7.03% |
| Dec 31, 2023 | 185 | -7 | -3.65% |
| Dec 31, 2022 | 192 | -4 | -2.04% |
| Dec 31, 2021 | 196 | -71 | -26.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AC Immune | 172 |
| Cabaletta Bio | 151 |
| X4 Pharmaceuticals | 143 |
| Nautilus Biotechnology | 130 |
| Foghorn Therapeutics | 106 |
| Immuneering | 53 |
| Protara Therapeutics | 46 |
| Reviva Pharmaceuticals Holdings | 14 |
PBYI News
- 19 days ago - Puma Biotechnology, Inc. (PBYI) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 19 days ago - Puma Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results - Business Wire
- 22 days ago - Puma Biotechnology to Present at TD Cowen's 46th Annual Health Care Conference - Business Wire
- 4 weeks ago - Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2025 Financial Results - Business Wire
- 5 weeks ago - Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 3 months ago - Puma Biotechnology Added to the NASDAQ Biotechnology Index (NBI) - Business Wire
- 4 months ago - Puma Biotechnology: Step By Step In Making A Transition - Seeking Alpha
- 4 months ago - Puma Biotechnology, Inc. (PBYI) Q3 2025 Earnings Call Transcript - Seeking Alpha